Back to search

Article

Rev1-Rev7 Complex Inhibitor JH-RE-06 Enhances Mitomycin C Chemosensitivity in HCT116 Colorectal Cancer Cells

2023-06-27

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Cancer cells can develop resistance to DNA interstrand crosslinker agents through a DNA repair bypass pathway called TLS. JH-RE-06, a TLS-targeting inhibitor, has been shown to increase melanoma cell susceptibility to cisplatin. Nevertheless, whether JH-RE-06 can be used in combination with Mitomycin C (MMC) to benefit Colorectal Cancer (CRC) patients receiving...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
921c1a14-0e54-507b-8944-fb7baf8668b6
DOI
10.21203/rs.3.rs-3071400/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rev1-Rev7 Complex Inhibitor JH-RE-06 Enhances Mitomycin C Chemosensitivity in HCT116 Colorectal Cancer CellsDOI 10.21203/rs.3.rs-3071400/v1
Select a neighboring publication to make it the new centre.